Skip to main content
. 2022 Oct 5;12(1):111–119. doi: 10.4103/EUS-D-21-00187

Table 1.

Low-grade risk factors associated with the detection of high-grade precancerous or cancerous pancreatic lesions in score positive patients

Without lesions (n=511) PHP (n=10) P (PHP vs. without lesions) Resectable lesions (n=20) P (resectable lesions vs. without lesions) All lesions (n=33) P (all lesions vs. without lesions) (univariate/multivariate logistic analysis)
Mean age±SD, years 67.9±12.2 70.4±7.1 0.526 70.6±8.8 0.336 71.9±9.3 0.070
Male sex, n (%) 312 (61.1) 8 (80.0) 0.239 16 (80.0) 0.098 21 (63.6) 0.087
LGRF n (%)
 Sporadic family history 73 (14.3) 2 (20.0) 0.613 4 (20.0) 0.479 4 (12.1) 0.730
 DM 185 (36.2) 3 (30.0) 0.687 6 (30.0) 0.572 11 (33.3) 0.739
 DM worsening 54 (10.6) 0 0.997 1 (5.0) 0.435 3 (9.1) 0.789
 Heavy drinking 199 (38.9) 7 (70.0) 0.062 11 (55.0) 0.156 14 (42.4) 0.692
 Smoking history 153 (29.9) 4 (40.0) 0.496 10 (50.0) 0.063 13 (39.4) 0.256
 Obesity 143 (30.0) 3 (30.0) 0.888 4 (20.0) 0.437 8 (24.2) 0.642
 Stomach symptoms or back pain 140 (27.4) 3 (30.0) 0.855 7 (35.0) 0.458 17 (51.5) 0.004*/0.060
 Weight loss 101 (19.8) 0 0.997 7 (35.0) 0.105 18 (54.5) <0.001*/0.001*
 Pancreatic enzyme 63 (12.3) 3 (30.0) 0.113 6 (30.0) 0.028* 8 (24.2) 0.055
Score valuation
 Mean LGRS±SD, point 2.2±1.5 2.5±1.0 0.459 2.8±1.1 0.056 2.9±1.0 0.004*/0.505
 LGRS positive, n (%) 230 (45.0) 6 (60.0) 0.353 13 (65.0) 0.086 24 (72.7) 0.003*/0.222

*P<0.05 compared to patients without pancreatic high-grade precancerous lesion and PC. DM: Diabetes mellitus; LGRF: Low-grade risk factors; LGRS: Low-grade risk score; PC: Pancreatic cancer; PHP: Pancreatic high-grade precancerous lesion; SD: Standard deviation